ACCEPT SIMS AI™ · BloomShield CIC

BloomShield-branded research demonstrator

RESEARCH DEMONSTRATOR — SYNTHETIC DATA ONLY — NOT FOR CLINICAL USE

Synthetic-data research demonstration · Mock mode — simulated responses, no live AI · Not for clinical use.

Integrated demonstration

Synthetic data only · Not for clinical use. Administrative decisions never establish diagnostic completion.

Load EXP-0885 · Site E · 15 November 2026

Load the fixed scenario above to follow the demonstration. Other filters and dates retain their own historical context.

Which intelligence is being demonstrated?
  • Model A: trained referral-time prediction evaluated on synthetic data, with a 60-day horizon and historical-cutoff safeguards.
  • Event-triggered review: deterministic navigation intelligence based on documented events; no new probability.
  • Generative AI: model-generated administrative recommendations in safeguarded Live mode. Mock mode uses a deterministic fixture and makes no model call.
  • Model B: proposed future dynamic prediction, not yet trained or implemented; no probability is available.
Uploads

Planned ingestion capabilities — not yet operational. This demonstration uses a fixed synthetic cohort.

  • Direct entry with mobile-friendly forms and future offline capabilities.
  • Validated CSV/Excel imports with schema, chronology and data-quality checks.
  • Secure integrations with existing records, laboratory and appointment systems, potentially using HL7 FHIR.

Programme dashboard

Screening activity and follow-up across the synthetic programme.

Site
Screening modality

Programme activity

Unique participants screened
4,325
Screening encounters
5,365
Diagnostic referrals
1,014
Outstanding pathways
297

Screening pathway

  1. Screening5,365Encounters
  2. Positive finding1,878Documented findings
  3. Referral1,014Diagnostic referrals
  4. Follow-up1,274Diagnostic visits
  5. Outcome717Resolved pathways

Stage totals use different units. Pending pathways: 297. Insufficient observation: 0.

Participant insight

Expanded synthetic participant 2425 · EXP-2425Synthetic · Site A

Full participant history through 2027-05-21, across modalities and pathways.

  1. · Screening · HPV DNA · Initial · Programme entry
  2. · Screening result · HPV DNA · HPV detected · Adequate
  3. · Repeat plan · HPV DNA · Prior HPV positive · Scheduled for 2027-07-19

Referral-time risk

No matching referral was available at this observation date.

Screened participants

4325 matching participants. Select a participant to review their timeline and referral-time risk.

ParticipantSite
EXP-2204 · Expanded synthetic participant 2204Site A — Urban Referral Hub
EXP-2205 · Expanded synthetic participant 2205Site A — Urban Referral Hub
EXP-2206 · Expanded synthetic participant 2206Site E — Resource-Constrained Navigation Programme
EXP-2207 · Expanded synthetic participant 2207Site D — Community Engagement Programme
EXP-2208 · Expanded synthetic participant 2208Site D — Community Engagement Programme
EXP-2209 · Expanded synthetic participant 2209Site C — Rural Outreach Programme
EXP-2210 · Expanded synthetic participant 2210Site C — Rural Outreach Programme
EXP-2211 · Expanded synthetic participant 2211Site B — Peri-Urban Access Programme
EXP-2212 · Expanded synthetic participant 2212Site A — Urban Referral Hub
EXP-2214 · Expanded synthetic participant 2214Site A — Urban Referral Hub
EXP-2215 · Expanded synthetic participant 2215Site D — Community Engagement Programme
EXP-2216 · Expanded synthetic participant 2216Site D — Community Engagement Programme
EXP-2218 · Expanded synthetic participant 2218Site E — Resource-Constrained Navigation Programme
EXP-2219 · Expanded synthetic participant 2219Site C — Rural Outreach Programme
EXP-2220 · Expanded synthetic participant 2220Site E — Resource-Constrained Navigation Programme
EXP-2221 · Expanded synthetic participant 2221Site D — Community Engagement Programme
EXP-2224 · Expanded synthetic participant 2224Site D — Community Engagement Programme
EXP-2225 · Expanded synthetic participant 2225Site B — Peri-Urban Access Programme
EXP-2226 · Expanded synthetic participant 2226Site B — Peri-Urban Access Programme
EXP-2228 · Expanded synthetic participant 2228Site C — Rural Outreach Programme
EXP-2229 · Expanded synthetic participant 2229Site B — Peri-Urban Access Programme
EXP-2230 · Expanded synthetic participant 2230Site B — Peri-Urban Access Programme
EXP-2231 · Expanded synthetic participant 2231Site C — Rural Outreach Programme
EXP-2233 · Expanded synthetic participant 2233Site E — Resource-Constrained Navigation Programme
EXP-2234 · Expanded synthetic participant 2234Site C — Rural Outreach Programme

Programme insights

Encounters by modality

VIA
1966
HPV DNA
2673
Cytology
726

Navigation activity

Barrier documented
923
Contact attempt
1482
Navigation intervention
416
Diagnostic booking
1283
Diagnostic visit
1274

Documented barriers

Contact difficulty
295
Transport difficulty
306
Appointment coordination
322

Site and modality select screening encounters. Pathway status limits the screened group to participants with a matching referral. Referral, navigation and barrier totals count events linked to matching pathways.